Stay updated with breaking news from Doing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- On July 11, 2022, VenusP-ValveTM, Venus Medtech's in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, was...
HANGZHOU, China, July 13, 2022 /PRNewswire/ -- On July 11, 2022, VenusP-ValveTM, Venus Medtech's in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, was approved by China's National Medical Products Administration (NMPA) for the treatment of severe pulmonary regurgitation (3+) in patients after congenital heart defects (CHD) procedure with native right ventricular outflow tract (RVOT). The approval has made VenusP-ValveTM the first TPVR product to be marketed in China, marking another milestone following its CE MDR approval. As the first self-expanding...
HANGZHOU, China, July 13, 2022 /PRNewswire/ -- On July 11, 2022, VenusP-ValveTM, Venus Medtech's in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, was approved
Women make up almost half the of the world population, and they are only now starting to raise their numbers in the national workforce and earn more graduate degrees than men. Yet the gender gap in science persists, to a greater degree than in...